Global Lipid Disorder Treatment Market Size By Drug Type, By Indication, By Distribution Channel, By Geographic Scope And Forecast

Lipid Disorder Treatment Market Size And Forecast

Lipid Disorder Treatment Market size was valued at USD 10.1 Billion in 2023 and is projected to reach USD 22.3 Billion by 2030, growing at a CAGR of 12.63% during the forecast period 2024-2030.

The growth of the Lipid Disorder Treatment Market can be credited to the incremental amounts of diseases such as obesity and high cholesterol owing to unhealthy lifestyle patterns which involves activities like smoking and consumption of alcoholic beverages. The Global Lipid Disorder Treatment Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Lipid Disorder Treatment Market Definition

A Lipid disorder is a health condition wherein the body contains high blood levels of Low-Density Lipoprotein (LDL) cholesterol, which is also called as “bad cholesterol”. It can also be characterized as the body having high levels of triglycerides, or fats, or both. High quantities of these elements increases the body’s risk of having a heart disease. There are several treatments for Lipid Disorders which includes statins, cholesterol absorption inhibitors, Bile Acid Sequestrants, Fibrates, Supplements and Lifestyle Changes.

Statins are medications which blocks the secretion of a chemical which is responsible for producing cholesterol. The Liver then removes the already existing cholesterol from our blood. Atorvastatin (Lipitor), Fluvastatin (Lescol), Rosuvastatin (Crestor), Simvastatin (Zocor) and Pravastatin. Cholesterol Absorption Inhibitors, which are sometimes used in a combination with statins, reduce our body’s intake of dietary cholesterol. Bile Acid sequestrants inhibit trap an element called bile resins, and its reabsorption in our small intestine. Fibrates help in lowering the levels of triglycerides in our blood, whereas supplements such as Omega 3 Fatty Acids are available over the counter and are used to lower the levels of bad cholesterol and triglycerides in our blood.

Global Lipid Disorder Treatment Market Overview

In the report, the market outlook section mainly encompasses fundamental dynamics of the market which include drivers, restraints, opportunities and challenges faced by the industry. Drivers and Restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market.

One of the primary growth drivers of the global Lipid Disorder Treatment market is the rising amount of bad cholesterol and fats globally. This is a result of unhealthy lifestyle transformations such as alcohol consumptions and smoking. A data by WHO claims that obesity levels has tripled since 1975, and in 2016, there 1.9 billion adults (18 years or older, were overweight) out of which 650 million people were obese. The rising amounts of obesity leads to lipid disorders in the body which needs medical attention, hence leading to the growth of lipid disorder treatment market. The prevalence of unhealthy lifestyle, especially among teens is a significant contributor. As per WHO, over 340 million children or adolescents, aged 5-19 were obese in 2016. Moreover, the increased prevalence of drinking and smoking has led to cardiovascular diseases among the population, which has fueled the demand for modern lipid lowering drugs. The COVID 19 pandemic as slowed the growth of Lipid disorder treatment market. Moreover, increasingly commercialized lifestyle, along with growing urbanization and rising consumption of alcohol and stress levels is likely to provide opportunities for growth of the Lipid Disorder Treatment Market.

Global Lipid Disorder Treatment Market Segmentation Analysis

The Global Lipid Disorder Treatment Market is Segmented on the basis of Drug Type, Indication,  Distribution Channel, And Geography.

By Drug Type

• Atorvastatin• Fluvastatin• Simvastatin• Pravastatin• Other Drugs

The Global Lipid Disorder Treatment Market is segmented into Atorvastatin, Fluvastatin, Simvastatin, Pravastatin and Other Drugs on the basis of Drug Type. Atorvastatin is expected to be the largest growing segment in the forecast period. It is due to the fact that Atorvastatin is considered to be an effective LDL lowering agents, as a consequence of which it is being produced in large scale by the leading manufacturers

By Indication

• Heterozygous Familial Hypercholesterolemia• Familial Hypertriglyceridemia• Familial Dysbetalipoproteinemia• Other Indications

The Global Lipid Disorder Treatment Market is segmented into Heterozygous Familial Hypercholesterolemia, Familial Hypertriglyceridemia, Familial Dysbetalipoproteinemia and Other Indications on the basis of Indications. Heterozygous Familial Hypercholesterolemia is a genetic disorder, which causes dangerously high cholesterol levels, which can lead to heart attacks if left untreated. Familial hypertriglyceridemia (type IV familial dyslipidemia) is a genetic disorder which causes the liver to overproduce very-low-density lipoproteins (VLDL). As a result, an afflicted individual will have an excessive number of VLDL and triglycerides on a lipid profile.

By Distribution Channel

• Hospital Pharmacies• Retail Pharmacies• Online Pharmacies• Others

The Global Lipid Disorder Treatment Market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others on the basis of distribution channel. Online Pharmacies is expected to have a large market in the forecast period and at present, due to people avoiding physical contact as much as possible, online health checkups, and easy access to high speed services

By Geography

• North America• Europe• Asia Pacific• Rest of the world

On the basis of Geography, the Global Lipid Disorder Treatment Market is classified into North America, Europe, Asia Pacific, and Rest of the world. Asia Pacific is expected to the fastest growing region for the market. It can be attributed to the growing population of teens, and a high prevalence of unhealthy lifestyle resulting to a large number of people suffering from obesity and heart diseases due to high amounts of bad cholesterol and unhealthy fats.

Key Players

The “Global Lipid Disorder Treatment Market” study report will provide a valuable insight with an emphasis on global market including some of the major players such as Mylan Pharmaceuticals, Teva Pharmaceuticals, Kowa Pharmaceuticals America Inc., Novartis AG, Pfizer Inc., Astrazeneca Plc, Sun Pharmaceuticals Industries Ltd., Glenmark Pharmaceuticals Ltd., Wockhardt Limited, Emcure Pharmaceuticals Ltd., and Others.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Report Scope

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.